<p>随着全球市场在利率调整和混合经济信号的复杂环境中航行，亚洲股市面临着自身的一系列挑战，日本经历了显著的加息，而中国的增长指标则显示出停滞的迹象。在这种环境下，识别被低估的股票对寻求相对当前市场估值潜在价值的投资者尤其具有吸引力。</p>
<h3>基于现金流的亚洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估计）</strong></td>
<td><strong>折扣（估计）</strong></td>
</tr>
<tr>
<td>西安诺瓦星云科技（SZSE:301589）</td>
<td>CN¥154.88</td>
<td>CN¥302.77</td>
<td>48.8%</td>
</tr>
<tr>
<td>三一重工国际控股（SEHK:631）</td>
<td>HK$8.50</td>
<td>HK$16.36</td>
<td>48.1%</td>
</tr>
<tr>
<td>汇量科技（SEHK:1860）</td>
<td>HK$15.40</td>
<td>HK$30.69</td>
<td>49.8%</td>
</tr>
<tr>
<td>Kuraray（TSE:3405）</td>
<td>¥1600.00</td>
<td>¥3167.00</td>
<td>49.5%</td>
</tr>
<tr>
<td>H.U.集团控股（TSE:4544）</td>
<td>¥3364.00</td>
<td>¥6592.59</td>
<td>49%</td>
</tr>
<tr>
<td>FIT Hon Teng（SEHK:6088）</td>
<td>HK$5.70</td>
<td>HK$11.22</td>
<td>49.2%</td>
</tr>
<tr>
<td>第一三共（TSE:4568）</td>
<td>¥3332.00</td>
<td>¥6544.37</td>
<td>49.1%</td>
</tr>
<tr>
<td>CURVES HOLDINGS（TSE:7085）</td>
<td>¥795.00</td>
<td>¥1573.75</td>
<td>49.5%</td>
</tr>
<tr>
<td>Cowell e Holdings（SEHK:1415）</td>
<td>HK$27.92</td>
<td>HK$55.44</td>
<td>49.6%</td>
</tr>
<tr>
<td>北京超强科技（SHSE:688411）</td>
<td>CN¥259.90</td>
<td>CN¥515.12</td>
<td>49.5%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们基于现金流的 273 只被低估亚洲股票的完整列表。</p>
<p>让我们深入探讨一些筛选出的优质选择。</p>
<h2>微创医疗（SEHK:853）</h2>
<p><strong>概述：</strong> 微创医疗科技有限公司，市值为 HK$198.8 亿，专注于在中国、欧洲、中东和非洲、日本及其他国际市场创新、制造和销售医疗设备。</p>
<p><strong>运营：</strong> 公司的收入主要来自其骨科设备业务（$249.94 百万）、心脏节律管理业务（$221.36 百万）、心血管设备业务（不包括 CRM）、外科机器人设备和心脏瓣膜业务（$161.90 百万）、血管内和外周血管设备业务（$158.41 百万）、神经血管设备业务（$102.90 百万）、结构性心脏病业务（$51.25 百万）和外科机器人设备业务（$46.54 百万）。</p>
<p><strong>公允价值折扣估计：</strong> 11.2%</p>
<p>微创医疗的交易价格为 HK$10.39，低于其估计的公允价值 HK$11.7，表明基于折现现金流分析的潜在低估。尽管预测的股本回报率较低，仅为 8.8%，但预计其收益将在三年内显著增长并实现盈利，超过市场平均增长率。最近的治理变更旨在增强决策过程，可能在长期内加强公司的战略方向和财务管理能力。</p>
<ul>
<li>我们最近的增长报告提供了微创医疗业务前景的良好预测。</li>
<li>在这里深入了解微创医疗的具体情况，查看我们的全面财务健康报告。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SEHK:853 截至 2025 年 12 月的折现现金流</p>
<h2>北京超强科技（SHSE:688411）</h2>
<p><strong>概述：</strong> 北京超强科技有限公司专注于在中国设计、开发、集成和运营储能电站，市值为 CN¥468.1 亿。</p>
<p><strong>运营：</strong> 收入细分（单位：百万 CN¥）：</p>
<p><strong>公允价值折扣估计：</strong> 49.5%</p>
<p>北京超强科技的当前交易价格为 CN¥259.9，相较于其估计的公允价值 CN¥515.12，基于折现现金流分析显著低估。预计公司的收入和收益将大幅增长，超过中国市场的整体增长率。尽管最近股价波动，最新的财报显示强劲表现，销售额达到 CN¥79.1 亿，净收入在 2025 年 9 月同比翻倍至 CN¥6.226 亿。</p>
<ul>
<li>我们编制的增长报告表明，北京超强科技的未来前景可能向好。</li>
<li>在这里深入分析完整的健康报告，以更深入了解北京超强科技。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SHSE:688411 截至 2025 年 12 月的折现现金流</p>
<h2>Chenbro Micom（TWSE:8210）</h2>
<p><strong>概述：</strong> Chenbro Micom 有限公司专注于全球计算机外设和系统的研发、设计、制造、加工和贸易，市值为 NT$1161.1 亿。</p>
<p><strong>运营：</strong> 公司的计算机外设收入为 NT$191.3 亿。</p>
<p><strong>公允价值折扣估计：</strong> 25.1%</p>
<p>Chenbro Micom 的交易价格为 NT$955，相较于其公允价值估计 NT$1275.28 被低估。公司财务健康状况良好，第三季度销售额从去年的 NT$42.7 亿上升至 NT$56.6 亿，净收入从 NT$6.4377 亿增加至 NT$9.9332 亿。预计未来三年收益将显著增长，超过台湾市场的增长率，尽管最近股价波动。</p>
<ul>
<li>我们的 Chenbro Micom 增长报告中的分析暗示未来财务表现强劲。</li>
<li>点击这里了解 Chenbro Micom 的细微差别，查看我们的详细财务健康报告。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TWSE:8210 截至 2025 年 12 月的折现现金流</p>
<h2>关键要点</h2>
<ul>
<li>深入了解我们在这里识别的 273 只基于现金流的被低估亚洲股票。</li>
<li>你已经投资这些股票了吗？通过设置 Simply Wall St 的投资组合，随时掌握每一个动态，让投资者像你一样保持信息灵通和积极主动。</li>
<li>使用 Simply Wall St 提升你的投资组合，这是寻求全球市场覆盖的投资者的终极应用程序。</li>
</ul>
<h2>准备好探索其他投资风格了吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过提供可靠收入来源的稳健分红股票来多元化你的投资组合，以应对潜在的市场波动。</li>
<li>用显示强劲增长潜力的公司来充实你的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议，也不构成买卖任何股票的推荐，并未考虑你的目标或财务状况。</strong> 我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>移动基础设施用于国防和灾难</p>
<p>下一波机器人技术不是人形的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，覆盖任何地方。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>代表 CiTech 赞助</p>

诺瓦星云

三一重工

汇量科技

<p>这篇文章强调了被低估的亚洲股票，其中一些股票的交易价格低于估计的公允价值 49.5%。文章指出了西安诺瓦星云科技、三一重工和汇量科技等顶级股票。微创医疗和北京超强科技被认为具有潜在的低估和增长前景。分析表明，这些股票可能基于折现现金流分析提供投资机会</p>

<p>As global markets navigate a complex landscape marked by interest rate adjustments and mixed economic signals, Asia's stock markets have faced their own set of challenges, with Japan experiencing significant rate hikes and China's growth indicators showing signs of stagnation. In this environment, identifying undervalued stocks can be particularly appealing to investors looking for opportunities that may offer potential value relative to current market valuations.</p>
<div class="lb-trans"><p>随着全球市场在利率调整和混合经济信号的复杂环境中航行，亚洲股市面临着自身的一系列挑战，日本经历了显著的加息，而中国的增长指标则显示出停滞的迹象。在这种环境下，识别被低估的股票对寻求相对当前市场估值潜在价值的投资者尤其具有吸引力。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基于现金流的亚洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Xi'an NovaStar Tech (SZSE:301589)</td>
<td>CN¥154.88</td>
<td>CN¥302.77</td>
<td>48.8%</td>
</tr>
<tr>
<td>Sany Heavy Equipment International Holdings (SEHK:631)</td>
<td>HK$8.50</td>
<td>HK$16.36</td>
<td>48.1%</td>
</tr>
<tr>
<td>Mobvista (SEHK:1860)</td>
<td>HK$15.40</td>
<td>HK$30.69</td>
<td>49.8%</td>
</tr>
<tr>
<td>Kuraray (TSE:3405)</td>
<td>¥1600.00</td>
<td>¥3167.00</td>
<td>49.5%</td>
</tr>
<tr>
<td>H.U. Group Holdings (TSE:4544)</td>
<td>¥3364.00</td>
<td>¥6592.59</td>
<td>49%</td>
</tr>
<tr>
<td>FIT Hon Teng (SEHK:6088)</td>
<td>HK$5.70</td>
<td>HK$11.22</td>
<td>49.2%</td>
</tr>
<tr>
<td>Daiichi Sankyo Company (TSE:4568)</td>
<td>¥3332.00</td>
<td>¥6544.37</td>
<td>49.1%</td>
</tr>
<tr>
<td>CURVES HOLDINGS (TSE:7085)</td>
<td>¥795.00</td>
<td>¥1573.75</td>
<td>49.5%</td>
</tr>
<tr>
<td>Cowell e Holdings (SEHK:1415)</td>
<td>HK$27.92</td>
<td>HK$55.44</td>
<td>49.6%</td>
</tr>
<tr>
<td>Beijing HyperStrong Technology (SHSE:688411)</td>
<td>CN¥259.90</td>
<td>CN¥515.12</td>
<td>49.5%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估计）</strong></td>
<td><strong>折扣（估计）</strong></td>
</tr>
<tr>
<td>西安诺瓦星云科技（SZSE:301589）</td>
<td>CN¥154.88</td>
<td>CN¥302.77</td>
<td>48.8%</td>
</tr>
<tr>
<td>三一重工国际控股（SEHK:631）</td>
<td>HK$8.50</td>
<td>HK$16.36</td>
<td>48.1%</td>
</tr>
<tr>
<td>汇量科技（SEHK:1860）</td>
<td>HK$15.40</td>
<td>HK$30.69</td>
<td>49.8%</td>
</tr>
<tr>
<td>Kuraray（TSE:3405）</td>
<td>¥1600.00</td>
<td>¥3167.00</td>
<td>49.5%</td>
</tr>
<tr>
<td>H.U.集团控股（TSE:4544）</td>
<td>¥3364.00</td>
<td>¥6592.59</td>
<td>49%</td>
</tr>
<tr>
<td>FIT Hon Teng（SEHK:6088）</td>
<td>HK$5.70</td>
<td>HK$11.22</td>
<td>49.2%</td>
</tr>
<tr>
<td>第一三共（TSE:4568）</td>
<td>¥3332.00</td>
<td>¥6544.37</td>
<td>49.1%</td>
</tr>
<tr>
<td>CURVES HOLDINGS（TSE:7085）</td>
<td>¥795.00</td>
<td>¥1573.75</td>
<td>49.5%</td>
</tr>
<tr>
<td>Cowell e Holdings（SEHK:1415）</td>
<td>HK$27.92</td>
<td>HK$55.44</td>
<td>49.6%</td>
</tr>
<tr>
<td>北京超强科技（SHSE:688411）</td>
<td>CN¥259.90</td>
<td>CN¥515.12</td>
<td>49.5%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 273 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>点击这里查看我们基于现金流的 273 只被低估亚洲股票的完整列表。</p>
</div><p>Let's dive into some prime choices out of the screener.</p>
<div class="lb-trans"><p>让我们深入探讨一些筛选出的优质选择。</p>
</div><h2>MicroPort Scientific (SEHK:853)</h2>
<div class="lb-trans"><h2>微创医疗（SEHK:853）</h2>
</div><p><strong>Overview:</strong> MicroPort Scientific Corporation, with a market cap of HK$19.88 billion, is involved in innovating, manufacturing, and marketing medical devices across the People's Republic of China, Europe, the Middle East and Africa, Japan, and other international markets.</p>
<div class="lb-trans"><p><strong>概述：</strong> 微创医疗科技有限公司，市值为 HK$198.8 亿，专注于在中国、欧洲、中东和非洲、日本及其他国际市场创新、制造和销售医疗设备。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Orthopedics Devices Business ($249.94 million), Cardiac Rhythm Management Business ($221.36 million), Cardiovascular Devices Business excluding CRM, Surgical Robot Device, and Heart Valve Business ($161.90 million), Endovascular and Peripheral Vascular Devices Business ($158.41 million), Neurovascular Devices Business ($102.90 million), Structural Heart Disease Business ($51.25 million), and Surgical Robot Devices Business ($46.54 million).</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其骨科设备业务（$249.94 百万）、心脏节律管理业务（$221.36 百万）、心血管设备业务（不包括 CRM）、外科机器人设备和心脏瓣膜业务（$161.90 百万）、血管内和外周血管设备业务（$158.41 百万）、神经血管设备业务（$102.90 百万）、结构性心脏病业务（$51.25 百万）和外科机器人设备业务（$46.54 百万）。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 11.2%</p>
<div class="lb-trans"><p><strong>公允价值折扣估计：</strong> 11.2%</p>
</div><p>MicroPort Scientific is trading at HK$10.39, below its estimated fair value of HK$11.7, indicating potential undervaluation based on discounted cash flow analysis. Despite a low forecasted return on equity of 8.8%, its earnings are expected to grow significantly and become profitable within three years, surpassing average market growth rates. Recent governance changes aim to enhance decision-making processes, potentially strengthening the company's strategic direction and financial management capabilities in the long term.</p>
<div class="lb-trans"><p>微创医疗的交易价格为 HK$10.39，低于其估计的公允价值 HK$11.7，表明基于折现现金流分析的潜在低估。尽管预测的股本回报率较低，仅为 8.8%，但预计其收益将在三年内显著增长并实现盈利，超过市场平均增长率。最近的治理变更旨在增强决策过程，可能在长期内加强公司的战略方向和财务管理能力。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for MicroPort Scientific's business outlook.</li>
<li>Dive into the specifics of MicroPort Scientific here with our thorough financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们最近的增长报告提供了微创医疗业务前景的良好预测。</li>
<li>在这里深入了解微创医疗的具体情况，查看我们的全面财务健康报告。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf?theme=light"/></p>
<p>SEHK:853 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>SEHK:853 截至 2025 年 12 月的折现现金流</p>
</div><h2>Beijing HyperStrong Technology (SHSE:688411)</h2>
<div class="lb-trans"><h2>北京超强科技（SHSE:688411）</h2>
</div><p><strong>Overview:</strong> Beijing HyperStrong Technology Co., Ltd. specializes in the design, development, integration, and operation of energy storage power stations in China, with a market cap of CN¥46.81 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京超强科技有限公司专注于在中国设计、开发、集成和运营储能电站，市值为 CN¥468.1 亿。</p>
</div><p><strong>Operations:</strong> Revenue Segments (in millions of CN¥):</p>
<div class="lb-trans"><p><strong>运营：</strong> 收入细分（单位：百万 CN¥）：</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 49.5%</p>
<div class="lb-trans"><p><strong>公允价值折扣估计：</strong> 49.5%</p>
</div><p>Beijing HyperStrong Technology, with a current trading price of CN¥259.9, is significantly undervalued compared to its estimated fair value of CN¥515.12 based on discounted cash flow analysis. The company's revenue and earnings are forecast to grow substantially, outpacing the broader Chinese market's growth rates. Despite recent share price volatility, recent earnings reports show strong performance with sales reaching CN¥7.91 billion and net income doubling year-over-year to CN¥622.6 million by September 2025.</p>
<div class="lb-trans"><p>北京超强科技的当前交易价格为 CN¥259.9，相较于其估计的公允价值 CN¥515.12，基于折现现金流分析显著低估。预计公司的收入和收益将大幅增长，超过中国市场的整体增长率。尽管最近股价波动，最新的财报显示强劲表现，销售额达到 CN¥79.1 亿，净收入在 2025 年 9 月同比翻倍至 CN¥6.226 亿。</p>
</div><ul>
<li>The growth report we've compiled suggests that Beijing HyperStrong Technology's future prospects could be on the up.</li>
<li>Delve into the full analysis health report here for a deeper understanding of Beijing HyperStrong Technology.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们编制的增长报告表明，北京超强科技的未来前景可能向好。</li>
<li>在这里深入分析完整的健康报告，以更深入了解北京超强科技。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf?theme=light"/></p>
<p>SHSE:688411 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>SHSE:688411 截至 2025 年 12 月的折现现金流</p>
</div><h2>Chenbro Micom (TWSE:8210)</h2>
<div class="lb-trans"><h2>Chenbro Micom（TWSE:8210）</h2>
</div><p><strong>Overview:</strong> Chenbro Micom Co., Ltd. is involved in the R&amp;D, design, manufacture, processing, and trading of computer peripherals and systems globally, with a market cap of NT$116.11 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Chenbro Micom 有限公司专注于全球计算机外设和系统的研发、设计、制造、加工和贸易，市值为 NT$1161.1 亿。</p>
</div><p><strong>Operations:</strong> The company's revenue from computer peripherals amounts to NT$19.13 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的计算机外设收入为 NT$191.3 亿。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 25.1%</p>
<div class="lb-trans"><p><strong>公允价值折扣估计：</strong> 25.1%</p>
</div><p>Chenbro Micom, trading at NT$955, is undervalued compared to its fair value estimate of NT$1,275.28. The company shows strong financial health with third-quarter sales rising to NT$5.66 billion from NT$4.27 billion year-over-year and net income increasing to NT$993.32 million from NT$643.77 million. Earnings are projected to grow significantly over the next three years, surpassing Taiwan's market growth rates despite recent share price volatility.</p>
<div class="lb-trans"><p>Chenbro Micom 的交易价格为 NT$955，相较于其公允价值估计 NT$1275.28 被低估。公司财务健康状况良好，第三季度销售额从去年的 NT$42.7 亿上升至 NT$56.6 亿，净收入从 NT$6.4377 亿增加至 NT$9.9332 亿。预计未来三年收益将显著增长，超过台湾市场的增长率，尽管最近股价波动。</p>
</div><ul>
<li>The analysis detailed in our Chenbro Micom growth report hints at robust future financial performance.</li>
<li>Click here to discover the nuances of Chenbro Micom with our detailed financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的 Chenbro Micom 增长报告中的分析暗示未来财务表现强劲。</li>
<li>点击这里了解 Chenbro Micom 的细微差别，查看我们的详细财务健康报告。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf?theme=light"/></p>
<p>TWSE:8210 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>TWSE:8210 截至 2025 年 12 月的折现现金流</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><ul>
<li>Dive into all 273 of the Undervalued Asian Stocks Based On Cash Flows we have identified here.</li>
<li>Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.</li>
<li>Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入了解我们在这里识别的 273 只基于现金流的被低估亚洲股票。</li>
<li>你已经投资这些股票了吗？通过设置 Simply Wall St 的投资组合，随时掌握每一个动态，让投资者像你一样保持信息灵通和积极主动。</li>
<li>使用 Simply Wall St 提升你的投资组合，这是寻求全球市场覆盖的投资者的终极应用程序。</li>
</ul>
</div><h2>Ready To Venture Into Other Investment Styles?</h2>
<div class="lb-trans"><h2>准备好探索其他投资风格了吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过提供可靠收入来源的稳健分红股票来多元化你的投资组合，以应对潜在的市场波动。</li>
<li>用显示强劲增长潜力的公司来充实你的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议，也不构成买卖任何股票的推荐，并未考虑你的目标或财务状况。</strong> 我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>移动基础设施用于国防和灾难</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是人形的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，覆盖任何地方。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 赞助</p>
</div>

三只亚洲股票的交易价格估计低于其公允价值，幅度最高可达 49.5%